POTSDAM, GERMANY -- (Marketwire) -- 07/08/10 -- Signature Diagnostics / Signature Diagnostics Presents Positive Colorectal Screening Study Results at the 12th World Congress on Gastrointestinal Cancer in Barcelona processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. * Blood-based test, Detector C, detected 90 percent of colorectal cancer cases and a substantial proportion of precancerous lesions * Product launch planned by year-end POTSDAM, Germany, July 8, 2010 - Signature Diagnostics announced today that on June 30 2010, company CEO, Andre Rosenthal, opened the scientific session of the European Society for Medical Oncology (ESMO) Conference:
More...
More...